In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA’s ban on low dose ephedra was not arbitrary or capricious.
Next stop, Supreme Court?
Neutraceutical Corp. v. Von Eschenbach, No. 05-4151 (Aug. 17, 2006)
About Joel Rothman
Joel B. Rothman represents clients in intellectual property infringement litigation involving patents, trademarks, copyrights, trade secrets, defamation, trade libel, unfair competition, unfair and deceptive trade practices, and commercial matters. Joel’s litigation practice also includes significant focus on electronic discovery issues such as e-discovery management and motion practice relating to e-discovery.
Trackbacks/Pingbacks